Detalles de la búsqueda
1.
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study).
Cancer Immunol Immunother
; 72(1): 91-99, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35729418
2.
Pharmacokinetic herb-drug interaction between ginger and crizotinib.
Br J Clin Pharmacol
; 86(9): 1892-1893, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30701569
3.
Different pathways to lung cancer diagnosis in a real-life setting.
Respir Med Res
; 86: 101108, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38843597
4.
Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer.
J Cancer Res Clin Oncol
; 149(16): 15095-15102, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37626173
5.
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study).
J Immunother
; 2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37807621
6.
Immune checkpoint inhibitors and hospitalization at home in France.
Bull Cancer
; 109(1): 89-97, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34785029
7.
Paclitaxel-bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study.
Ther Adv Med Oncol
; 14: 17588359221099399, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35694190
8.
Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine.
Front Med (Lausanne)
; 6: 233, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31737634
9.
Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017.
Lung Cancer
; 131: 122-127, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31027688
10.
ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer.
Lung Cancer
; 116: 15-24, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29413046
11.
Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report.
J Med Case Rep
; 11(1): 262, 2017 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28915906
12.
Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report.
J Med Case Rep
; 11(1): 183, 2017 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28679408
13.
A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.
Clin Lung Cancer
; 20(5): e535-e540, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171381
Resultados
1 -
13
de 13
1
Próxima >
>>